glutathione mutations in sclc patients Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs therapy Ferroptosis response segregates small cell
Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes Nature Communications In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Science Advances Oncology Reports Small cells big issues: biological implications and preclinical advancements in small cell lung cancer Molecular Cancer Springer Nature Link
Pay in 4 interest-free payments of $7.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22



